Log in

LON:DDDD - 4d Pharma Share Price, Forecast & News

GBX 99
-0.50 (-0.50 %)
(As of 01/17/2020 04:00 PM ET)
Today's Range
Now: GBX 99
50-Day Range
MA: GBX 100.10
52-Week Range
Now: GBX 99
Volume7,005 shs
Average Volume16,686 shs
Market Capitalization£64.84 million
P/E RatioN/A
Dividend YieldN/A
4D pharma plc engages in the research, development, and production of live biotherapeutic products. The company's development programs include Blautix for irritable bowel syndrome and Thetanix for paediatric crohn's disease, as well as Rosburix for Paediatric Ulcerative Colitis. It also develops immuno-oncology products, including MRx0518 for solid tumors; respiratory products, such as MRx0004 for asthma and MRx0001 for allergic asthma; autoimmune products comprising MRx0002 for multiple sclerosis and MRx0006 for rheumatoid arthritis; and CNS products for autism. 4D pharma plc has a collaboration agreement with Merck & Co., Inc. to conduct a clinical trial evaluating the combination of KEYTRUDAÂ and MRx0518 in patients with solid tumours. The company was formerly known as Schosween 18 Limited. 4D pharma plc was founded in 2014 and is headquartered in Leeds, the United Kingdom.

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual SalesN/A
Cash FlowGBX 19.41 per share
Book ValueGBX 53.40 per share



Market Cap£64.84 million
Next Earnings DateN/A
OptionableNot Optionable

Receive DDDD News and Ratings via Email

Sign-up to receive the latest news and ratings for DDDD and its competitors with MarketBeat's FREE daily newsletter.

Why Firing Your Internet Provider Could Save You $19,494 (Ad)

A brand-new technology - code named "Halo-Fi" - could kill off your overpriced cable company for good... beaming lightning-fast internet to your home for an estimated $7 a month.

This is undoubtedly the beginning of the end for "Big 3" internet providers.

Forward-thinking investors in Halo-Fi are lining up to get rich before January 30th.

4d Pharma (LON:DDDD) Frequently Asked Questions

What is 4d Pharma's stock symbol?

4d Pharma trades on the London Stock Exchange (LON) under the ticker symbol "DDDD."

Has 4d Pharma been receiving favorable news coverage?

Media headlines about DDDD stock have been trending somewhat negative this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. 4d Pharma earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for 4d Pharma.

Who are some of 4d Pharma's key competitors?

What other stocks do shareholders of 4d Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 4d Pharma investors own include Cray (CRAY), Oracle (ORCL), Universal Health Services (UHS), Amigo (AMGO), Ashtead Group (AHT), Telefonica Deutschland (O2D), Fresenius Medical Care AG & Co. KGaA (FME), Bayerische Motoren Werke (BMW), Rifco (RFC) and Prize Mining (PRZ).

Who are 4d Pharma's key executives?

4d Pharma's management team includes the folowing people:
  • Mr. Duncan Joseph Peyton, CEO & Exec. Director (Age 49)
  • Dr. Alexander James Stevenson, Chief Scientific Officer & Exec. Director (Age 47)
  • Mr. Stephen Dunbar, Fin. Director
  • Fay Weston, Head of Investor Relations
  • Mr. Laurence Dale, Gen. Counsel & Company Sec.

How do I buy shares of 4d Pharma?

Shares of DDDD and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is 4d Pharma's stock price today?

One share of DDDD stock can currently be purchased for approximately GBX 99.

How big of a company is 4d Pharma?

4d Pharma has a market capitalization of £64.84 million. 4d Pharma employs 93 workers across the globe.View Additional Information About 4d Pharma.

What is 4d Pharma's official website?

The official website for 4d Pharma is http://www.4dpharmaplc.com/.

How can I contact 4d Pharma?

4d Pharma's mailing address is 9 Bond Court, LEEDS, LS1 2JZ, United Kingdom. The company can be reached via phone at +44-113-8950130.

MarketBeat Community Rating for 4d Pharma (LON DDDD)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  38 (Vote Outperform)
Underperform Votes:  31 (Vote Underperform)
Total Votes:  69
MarketBeat's community ratings are surveys of what our community members think about 4d Pharma and other stocks. Vote "Outperform" if you believe DDDD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DDDD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/18/2020 by MarketBeat.com Staff

Featured Article: What is the Current Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel